GH Research Plc (GHRS)
21.04
-1.40
(-6.24%)
USD |
NASDAQ |
May 07, 14:15
GH Research Free Cash Flow : -45.04M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Definium Therapeutics, Inc. | -131.84M |
| Compass Pathways Plc | -157.61M |
| Atai Beckley, Inc. | -117.10M |
| Jazz Pharmaceuticals Plc | 1.186B |
| Nektar Therapeutics | -208.68M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.26M |
| Cash from Investing (Quarterly) | 8.566M |
| Cash from Financing (Quarterly) | -2.131M |
| Free Cash Flow Per Share (Quarterly) | -0.1979 |
| Free Cash Flow to Equity (Quarterly) | -12.20M |
| Free Cash Flow to Firm (Quarterly) | -12.18M |
| Free Cash Flow Yield | -3.51% |